Nuveen S&P 500 Buy-Write Income Fund
BXMX · NYSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.16 | -0.12 | 0.02 | -0.16 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 37.42 | 16.20 | 10.08 | 0.00 |
| Quality | ||||
| ROIC | 2.41% | 5.58% | 0.30% | 18.84% |
| Gross Margin | 0.00% | 68.53% | 70.50% | 100.00% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 3.36% | 45.32% | 36.55% | 32.53% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.24 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -236.10 | 22.75 | 567.26 | 9.73 |